• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.西班牙化脓性链球菌分离株中大环内酯类药物消费量与红霉素耐药率之间省级差异的药物流行病学分析。
J Clin Microbiol. 2002 Aug;40(8):2959-63. doi: 10.1128/JCM.40.8.2959-2963.2002.
2
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997).西班牙化脓性链球菌对红霉素的耐药性与大环内酯类药物使用情况的关系(1986 - 1997年)
J Antimicrob Chemother. 2000 Dec;46(6):959-64. doi: 10.1093/jac/46.6.959.
3
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.意大利中部地区化脓性链球菌的红霉素耐药性及大环内酯类药物的使用情况
Infection. 2009 Aug;37(4):353-7. doi: 10.1007/s15010-008-8023-1. Epub 2008 Dec 5.
4
Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.肺炎链球菌抗生素使用的局部差异以及红霉素和青霉素耐药性的地理差异的重要性。
J Clin Microbiol. 2002 Jan;40(1):159-64. doi: 10.1128/JCM.40.1.159-164.2002.
5
[Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption].[意大利东北部某地区化脓性链球菌大环内酯类耐药性消失:与合理使用长效大环内酯类药物的可能关联]
Infez Med. 2009 Jun;17(2):82-7.
6
Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.西班牙对红霉素耐药、对克林霉素和米欧卡霉素敏感(M表型)的化脓性链球菌患病率显著上升。
J Antimicrob Chemother. 2003 Feb;51(2):333-7. doi: 10.1093/jac/dkg100.
7
Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.16元环大环内酯类药物及泰利霉素对不同基因型的红霉素敏感及耐药化脓性链球菌和肺炎链球菌的活性。
J Antimicrob Chemother. 2007 Jun;59(6):1171-6. doi: 10.1093/jac/dkm089. Epub 2007 Apr 3.
8
Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin.大环内酯类药物的使用与化脓性链球菌对红霉素耐药性的发展。
Pharm World Sci. 2005 Apr;27(2):104-7. doi: 10.1007/s11096-004-6607-0.
9
High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.红霉素耐药、克林霉素/米诺卡霉素敏感(M表型)化脓性链球菌的高流行率:1998年西班牙多中心研究结果。西班牙初级卫生保健环境感染研究小组
J Antimicrob Chemother. 2000 May;45(5):605-9. doi: 10.1093/jac/45.5.605.
10
Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.1997 - 2001年芬兰大环内酯类药物消费对化脓性链球菌红霉素耐药性的影响。
Clin Infect Dis. 2004 May 1;38(9):1251-6. doi: 10.1086/383309. Epub 2004 Apr 14.

引用本文的文献

1
Systemic antibiotic use among children and adolescents in Germany: a population-based study.德国儿童和青少年的全身用抗生素使用情况:一项基于人群的研究。
Eur J Pediatr. 2013 Jun;172(6):787-95. doi: 10.1007/s00431-013-1958-y. Epub 2013 Feb 10.
2
Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.在治疗期间和治疗后,血液、组织和细胞内的红霉素及其代谢产物无环红霉素浓度。
Antimicrob Agents Chemother. 2012 Feb;56(2):1059-64. doi: 10.1128/AAC.05490-11. Epub 2011 Nov 14.
3
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.社区获得性呼吸道感染中的耐药性:新兴抗菌药物的作用。
Infect Drug Resist. 2010;3:35-43. doi: 10.2147/idr.s8964. Epub 2010 Jun 18.
4
Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.革兰氏阳性病原体的种群生物学:传播抗生素耐药性的高危克隆。
FEMS Microbiol Rev. 2011 Sep;35(5):872-900. doi: 10.1111/j.1574-6976.2011.00284.x. Epub 2011 Jul 4.
5
Cefditoren in upper and lower community-acquired respiratory tract infections.头孢地尼用于上下呼吸道社区获得性感染
Drug Des Devel Ther. 2011 Feb 9;5:85-94. doi: 10.2147/DDDT.S9499.
6
Population biology of the human restricted pathogen, Streptococcus pyogenes.人类特异性病原体化脓性链球菌的种群生物学
Infect Genet Evol. 2009 Jul;9(4):581-93. doi: 10.1016/j.meegid.2009.03.002. Epub 2009 Mar 21.
7
Erythromycin resistance in Streptococcus pyogenes and macrolide consumption in a central Italian region.意大利中部地区化脓性链球菌的红霉素耐药性及大环内酯类药物的使用情况
Infection. 2009 Aug;37(4):353-7. doi: 10.1007/s15010-008-8023-1. Epub 2008 Dec 5.
8
Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.甲氧苄啶-磺胺甲恶唑的使用与肺炎链球菌、流感嗜血杆菌和卡他莫拉菌耐药性之间的关联。
Antimicrob Agents Chemother. 2008 Jul;52(7):2480-5. doi: 10.1128/AAC.01118-07. Epub 2008 Apr 28.
9
Antibiotic resistant beta-hemolytic streptococci.耐抗生素的β-溶血性链球菌
Indian J Pediatr. 2007 Dec;74(12):1077-80. doi: 10.1007/s12098-007-0200-1.
10
Evolution and global dissemination of macrolide-resistant group A streptococci.耐大环内酯类A组链球菌的进化与全球传播
Antimicrob Agents Chemother. 2006 Sep;50(9):2903-11. doi: 10.1128/AAC.00325-06.

本文引用的文献

1
The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.葡萄球菌及其他伤口细菌对红霉素、竹桃霉素和螺旋霉素的敏感性。
J Clin Pathol. 1959 Mar;12(2):163-9. doi: 10.1136/jcp.12.2.163.
2
A European study on the relationship between antimicrobial use and antimicrobial resistance.一项关于抗菌药物使用与抗菌药物耐药性之间关系的欧洲研究。
Emerg Infect Dis. 2002 Mar;8(3):278-82. doi: 10.3201/eid0803.010192.
3
Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes.重组和生态位分离对病原体化脓性链球菌群体遗传结构的影响。
Infect Immun. 2002 Apr;70(4):1971-83. doi: 10.1128/IAI.70.4.1971-1983.2002.
4
Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.肺炎链球菌抗生素使用的局部差异以及红霉素和青霉素耐药性的地理差异的重要性。
J Clin Microbiol. 2002 Jan;40(1):159-64. doi: 10.1128/JCM.40.1.159-164.2002.
5
Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.德国侵袭性肺炎球菌分离株中大环内酯类和青霉素耐药性的出现。
J Antimicrob Chemother. 2002 Jan;49(1):61-8. doi: 10.1093/jac/49.1.61.
6
High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children.希腊儿童中化脓性链球菌对红霉素耐药的高流行率。
Pediatr Infect Dis J. 2001 Sep;20(9):863-8. doi: 10.1097/00006454-200109000-00008.
7
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.1684株肺炎链球菌和2039株化脓性链球菌分离株的抗菌药敏性及其生态关系:西班牙一项为期1年(1998 - 1999年)的多中心监测研究结果
Antimicrob Agents Chemother. 2001 Dec;45(12):3334-40. doi: 10.1128/AAC.45.12.3334-3340.2001.
8
Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.部门对抗生素药物的使用及后续耐药性:一种定量关联
J Antimicrob Chemother. 2001 Oct;48(4):535-40. doi: 10.1093/jac/48.4.535.
9
Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999.1994年至1999年期间荷兰肺炎链球菌的抗生素使用情况及耐药性
J Antimicrob Chemother. 2001 Sep;48(3):441-4. doi: 10.1093/jac/48.3.441.
10
Minimizing potential resistance: a population dynamics view.最小化潜在抗性:种群动态视角
Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S161-9. doi: 10.1086/321843.

西班牙化脓性链球菌分离株中大环内酯类药物消费量与红霉素耐药率之间省级差异的药物流行病学分析。

Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.

作者信息

García-Rey C, Aguilar L, Baquero F, Casal J, Martín J E

机构信息

Medical Department, GlaxoSmithKline, Tres Cantos, Spain.

出版信息

J Clin Microbiol. 2002 Aug;40(8):2959-63. doi: 10.1128/JCM.40.8.2959-2963.2002.

DOI:10.1128/JCM.40.8.2959-2963.2002
PMID:12149359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC120652/
Abstract

The M phenotype is by far the most common mechanism of erythromycin resistance among Streptococcus pyogenes isolates in Spain. A geographic analysis of the relationship between within-country differences in the prevalence of M-type resistance to erythromycin in S. pyogenes and the level of consumption of 14- and 15-membered macrolides within different provinces was carried out. From 1998 to 1999, a nationwide multicenter surveillance study yielded 2,039 consecutive pharyngeal isolates of S. pyogenes. Data on antibiotic consumption for the same period were gathered from IMS Health, and the corresponding daily defined doses per 1,000 inhabitants per day were calculated according to the Anatomic Therapeutic Classification index. Macrolide use was subdivided into dosages given three times a day (TID), twice a day (BID), or once a day (OD). Spearman nonparametric correlation coefficients (R) were calculated, and variables proving to be significantly associated (P < 0.1) were introduced into a linear regression model. The total consumption of macrolides presented a significant correlation with the prevalence of resistance (R = 0.527; P = 0.032). Neither TID nor BID macrolide consumption showed significant correlations. Only OD consumption had a significance below 0.1. These data are consistent with the hypothesis that only the total consumption of macrolides influences the local rates of M-type erythromycin resistance in S. pyogenes, and subgroups of macrolides seem to have an additive rather than a selective effect by contributing to increasing the final amount of macrolides used. Local variations in total consumption were associated only with BID consumption (R = 0.849; P = 0.004). The simple linear regression with total macrolide consumption showed a considerable determination coefficient (R(2) = 0.678; P = 0.006). The model explains up to 68% of the measured variation and is clearly better as a predictor of the prevalence of resistance than the mere mean is. By solving the regression equation, the resultant value of 2.2 defined doses per 1,000 inhabitants per day fits with the existence of a critical threshold of selective pressure.

摘要

在西班牙,M表型是化脓性链球菌分离株中红霉素耐药最常见的机制。对化脓性链球菌中M型红霉素耐药率在国内不同地区的差异与不同省份14元和15元大环内酯类药物的消费水平之间的关系进行了地理分析。1998年至1999年,一项全国性多中心监测研究连续获得了2039株化脓性链球菌咽部分离株。同期抗生素消费数据从IMS Health收集,并根据解剖治疗分类指数计算每1000居民每天相应的限定日剂量。大环内酯类药物的使用分为每日三次(TID)、每日两次(BID)或每日一次(OD)给药剂量。计算了Spearman非参数相关系数(R),并将证明有显著关联(P < 0.1)的变量引入线性回归模型。大环内酯类药物的总消费量与耐药率呈显著相关性(R = 0.527;P = 0.032)。TID和BID大环内酯类药物消费均未显示出显著相关性。只有OD消费量具有低于0.1的显著性。这些数据与以下假设一致,即只有大环内酯类药物的总消费量会影响化脓性链球菌中M型红霉素耐药的局部发生率,并且大环内酯类药物的亚组似乎通过增加最终使用的大环内酯类药物总量而具有累加效应而非选择效应。总消费量的局部差异仅与BID消费量相关(R = 0.849;P = 0.004)。与大环内酯类药物总消费量的简单线性回归显示出相当大的决定系数(R² = 0.678;P = 0.006)。该模型解释了高达68%的测量变异,并且作为耐药率的预测指标明显优于单纯的平均值。通过求解回归方程,每1000居民每天2.2个限定日剂量的结果值符合选择性压力临界阈值的存在情况。